Roger Ulrich recently joined Code-N’s advisory board after completing the merger of the company he founded, Calistoga Pharmaceuticals, with Gilead Sciences. Be sure to also read commentaries by Dr. Christian Fibiger and Dr. Paul Pearson. As when we talked to Christian and Paul, we began by asking Roger what he views as the primary challenges in drug […]
Read more »